Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunoprophylaxis to prevent mother-to-child transmission of HIV-1.
Safrit JT, Ruprecht R, Ferrantelli F, Xu W, Kitabwalla M, Van Rompay K, Marthas M, Haigwood N, Mascola JR, Luzuriaga K, Jones SA, Mathieson BJ, Newell ML; Ghent IAS Working Group on HIV in Women Children. Safrit JT, et al. Among authors: marthas m. J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):169-77. doi: 10.1097/00126334-200402010-00012. J Acquir Immune Defic Syndr. 2004. PMID: 14722451 Review.
Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus.
Van Rompay KK, Kearney BP, Sexton JJ, Colón R, Lawson JR, Blackwood EJ, Lee WA, Bischofberger N, Marthas ML. Van Rompay KK, et al. Among authors: marthas ml. J Acquir Immune Defic Syndr. 2006 Sep;43(1):6-14. doi: 10.1097/01.qai.0000224972.60339.7c. J Acquir Immune Defic Syndr. 2006. PMID: 16810108
The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters.
Van Rompay KK, Singh RP, Brignolo LL, Lawson JR, Schmidt KA, Pahar B, Canfield DR, Tarara RP, Sodora DL, Bischofberger N, Marthas ML. Van Rompay KK, et al. J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):900-14. doi: 10.1097/00126334-200408010-00003. J Acquir Immune Defic Syndr. 2004. PMID: 15220696
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.
Van Rompay KK, Abel K, Lawson JR, Singh RP, Schmidt KA, Evans T, Earl P, Harvey D, Franchini G, Tartaglia J, Montefiori D, Hattangadi S, Moss B, Marthas ML. Van Rompay KK, et al. J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):124-34. doi: 10.1097/00126334-200502010-00002. J Acquir Immune Defic Syndr. 2005. PMID: 15671796
Prophylactic ZDV dosing frequency in macaques.
van Rompay KK, Marthas ML, Pedersen NC. van Rompay KK, et al. Among authors: marthas ml. J Acquir Immune Defic Syndr (1988). 1994 Jun;7(6):627-9. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8192813 No abstract available.
Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals.
Greenier JL, Van Rompay KK, Montefiori D, Earl P, Moss B, Marthas ML. Greenier JL, et al. Virol J. 2005 Feb 14;2:11. doi: 10.1186/1743-422X-2-11. Virol J. 2005. PMID: 15710048 Free PMC article.
"The Duesberg phenomenon": what does it mean?
Van Rompay K, Marthas ML. Van Rompay K, et al. Among authors: marthas ml. Science. 1995 Jan 13;267(5195):157. doi: 10.1126/science.7809614. Science. 1995. PMID: 7809614 No abstract available.
84 results